Ignite Creation Date:
2025-12-26 @ 2:40 PM
Ignite Modification Date:
2026-01-20 @ 3:38 PM
Study NCT ID:
NCT03963206
Status:
COMPLETED
Last Update Posted:
2025-12-01
First Post:
2019-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE)
Sponsor:
Hospices Civils de Lyon